Conditions: Pain Due to Osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 101
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the efficacy and safety of OPC-249 by once daily inhalation at 0 (placebo), 30, 60 or 120 IU for 4 weeks in patients with pain due to osteoporosis.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: OPC-249
Intervention descriptions: intervention 1: 1 pugh/day for 4 weeks (30 IU, 60IU, or 90IU)

Protocol document: